Specific nucleotides at the 3′-terminal promoter of viral hemorrhagic septicemia virus are important for virulence in vitro and in vivo  by Kim, Sung-Hyun et al.
Speciﬁc nucleotides at the 30-terminal promoter of viral hemorrhagic
septicemia virus are important for virulence in vitro and in vivo
Sung-Hyun Kim a, Tz-Chun Guo a, Vikram N. Vakharia b, Øystein Evensen a,n
a Norwegian University of Life Sciences, Faculty of Veterinary Medicine and Bioproduction, P.O. Box 8146 Dep, N-0033 Oslo, Norway
b Institute of Marine & Environmental Technology, University of Maryland Baltimore County, 701 East Pratt Street, Baltimore 21202, USA
a r t i c l e i n f o
Article history:
Received 9 August 2014
Returned to author for revisions
12 September 2014
Accepted 2 December 2014
Available online 30 December 2014
Keywords:
VHSV
Novirhabdovirus
30-UTR
Promoter function
Virulence
In vitro
In vivo
a b s t r a c t
Viral hemorrhagic septicemia virus (VHSV), a member of the Novirhabdovirus genus, contains an 11-
nucleotide conserved sequence at the terminal 30- and 50-untranslated regions (UTRs) that are complemen-
tary. To study the importance of nucleotides in the 30-UTR of VHSV for replication of novirhabdoviruses, we
performed site-directed mutagenesis of selected residues at the 30-terminus and generated mutant viruses
using a reverse genetics approach. Assessment of growth kinetics and in vitro real-time cytopathogenicity
studies showed that the order of two nucleotides (A4G5) of the 30-terminus of VHSV directly affects growth
kinetics in vitro. The mutant A4G-G5A virus has reduced total positive-strand RNA synthesis efﬁciency (51%
of wild-type) at 48 h post-transfection and 70 h delay in causing complete cytopathic effect in susceptible
ﬁsh cells, as compared to the WT-VHSV. Furthermore, when the A4G-G5A virus was used to challenge
zebraﬁsh, it exhibited reduced pathogenicity (54% lower end-point mortality) compared to the WT-VHSV.
From these studies, we infer that speciﬁc residues in the 30-UTR of VHSV have a promoter function and are
essential to modulate the virulence in cells and pathogenicity in ﬁsh.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Viral hemorrhagic septicemia virus (VHSV) of the genus Novirhabdo-
virus and the family Rhabdoviridae belongs to the orderMononegavirales
(King et al., 2012). It has a linear non-segmented negative strand (NNS)
RNA genome of 11 kb which contains the nucleocapsid protein (N),
phosphoprotein (P), matrix protein (M), glycoprotein (G), RNA polymer-
ase (L), and nonstructural NV gene (Schutze et al., 1999). The VHSV
genome contains an 11 nucleotide-long, conserved sequences at the 30-
and 50-termini that are unusual for high A/U content and complemen-
tary (Whelan et al., 2010). The terminal conserved and complementary
sequences at the 30- and 50-termini are also found in other members of
the order Mononegavirales (family Rhabdoviridae, Filoviridae, and Para-
myxoviridae) (King et al., 2012). Based on vesicular stomatitis virus (VSV,
the genus Vesiculovirus in the family Rhabdoviridae), it has been shown
that the initiation of transcription and replication likely occurs at two
different sites in the 30-region of the virus (Whelan and Wertz, 2002;
Chuang and Perrault, 1997;Qanungo et al., 2004). Furthermore, two
polymerase complexes, one containing L and P and the other replicase
complex containing N, P and L were proposed to control transcription
and replication in VSV (Qanungo et al., 2004) but it is still unclear how
the polymerase complexes are initiated at the 30-terminus versus the N
gene start (Galloway and Wertz, 2009). It is believed that the intracel-
lular concentration of N that encapsidate the nascent leader RNA is a
regulator for RNA-dependent-RNA polymerase (RdRp) activity switching
from transcription to replication (Blumberg and Kolakofsky, 1981;
Blumberg et al., 1983;Whelan et al., 2010).
In the family Paramyxoviridae and Rhabdoviridae (lyssavirus, rabies
virus, and vesiculovirus), the terminal promoter regions have been
shown to be multifunctional and not only are required for control of
transcription and replication but also for encapsidation and assembly
of newly synthesized RNAs (Whelan et al., 2010). However, no such
information exists for the novirhabdoviruses and the underlying
mechanisms governing the switch from transcription to replication
mode have never been examined for the novirhabdoviruses. Our
notion was that the conserved primary sequence which has A/U-rich
content at the 30- untranslated region (UTR) terminus may function as
a potential promoter that could impact the transcription or/and
replication of the virus (Grinnell and Wagner, 1984). We found that
the 30-UTR terminus nucleotides are 30-C1AUA4G5UA7U8UUU11 and
while C1AUA4 and U8UUU11 are complementary with the 50-termi-
nus, G5UA7 is not. The in silico secondary RNA structure is similar to
the panhandle secondary RNA structure of inﬂuenza virus (Orthomyx-
oviridae) (Baudin et al., 1994) but there are no documentation in the
literature that a panhandle structure is formed in novirhabdoviruses.
We used this information as a guide and mutated the positions
deﬁned at the end and beginning of complimentarity (position
4 and 8 from the 30 end) and beginning of non-complimentarity
(positions 5 and 7), with the purpose to understand the importance of
the 30-terminal primary sequence for virus transcription and
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replication using site-directed mutagenesis and reverse genetics. The
resulting mutant VHSVs were characterized by strand-speciﬁc quanti-
tative RT-PCR (Matzinger et al., 2013;Purcell et al., 2006), growth
kinetics, in vitro real-time cytopathogenicity, and challenge studies in
zebraﬁsh to assess the role of 30- terminal speciﬁc sequence (A4G5) in
replication and pathogenicity of the virus.
Results
Reduced RNA synthesis process rate of A4G-G5A corresponds with
lower protein synthesis
To compare the viral protein expression level of VHSV mutants to
that of rWT-VHSV (1st passage), the virus-speciﬁc N protein was
detected in Epithelioma papulosum cyprini (EPC) cells by the indirect
ﬂuorescent antibody test (IFAT) (Fig. 1). The A4G-G5A variant exhibited
reduced infectivity as evidenced by the reduced ﬂuorescence (if any),
whereas the other variants (A7C-U8A and U8C) yielded strong
ﬂuorescencewhich was comparable to rWT-VHSV (Fig. 1). The rescued
viral titer of A4G-G5A variant (from supernatant) was 3 logs less than
other variants and WT-VHSV control at 5 days post-transfection (not
shown). To clarify the reason of the low infectivity of the A4G-G5A, we
examined the efﬁciencies of RNA synthesis processes at 2 days post-
transfection by using a strand-speciﬁc quantitative RT-PCR (ssqRT-
PCR) to separately quantify the positive strand RNAs (mRNA and
cRNA) and negative-strand RNA (viral RNA) at early time-points post-
transfection. We anticipated that the reverse primer () would favor
mRNA (þ) and cRNA (þ) levels while the forward primer (þ) will
favor negative-strand RNA expressions. We found that A4G-G5A
variant had signiﬁcant decrease of total positive-strand (51%) at 2 days
post-transfection compared to a non-mutated control (rWT), while
there was no difference indicating lower level of virus negative-strand
(Fig. 2a). ssq RT-PCR will not differentiate between mRNA and cRNA
and the CMV promoter will produce cRNA from the antigenome
plasmid which may account for a portion of the measured RNA (þ) by
ssqRT-PCR. The relative contribution was shown to be minimal (o1%)
of the total cRNA using a control without pL helper plasmid (Fig. 2b).
These ﬁndings are in favor of a reduction in cRNA synthesis in the
A4G-G5A variant. By western blot viral proteins generated frommRNA
(G and NV) are low at 2 days post-transfection (Fig. 3b) while present
at 5 days post-transfection, expect for A4G-G5A where G protein is
hardly discernible (Fig. 3b). Post-infection using rescued A4G-G5A
showed delayed expression of N and P protein compared to WT-VHSV
(Fig. 3a). Concurrently it took an additional 24 h for this variant to
reach a viral titer comparable to WT-VHSV (Fig. 4).
30-terminal mutations impact growth kinetics that corresponds with
cytopathic effects of recombinant VHSV strains in vitro
The rescued recombinant VHSV strains (2nd passage) were then
used to study infection kinetics in EPC (MOI¼0.1). A4G-G5A had a
slower growth pattern (in conformity with what was shown for the
viral protein expression; Fig. 3). We observed that A4G-G5A virus
grew even slower with no increase in titer by 2 days post-infection,
whereas the ﬁnal titer was comparable to the WT virus (Fig. 4). These
studies indicate that the A4G-G5A virus has delayed growth during
early stages of infection.
To study the cell viability post-infection in real-time, we used the
XCELLigence (Roche) system, which shows that U8C virus induced a
drop in cell viability 4 h earlier than the WT-VHSV (Fig. 5a). For A7C-
U8A virus, the loss of cell viability was delayed by 30 h and for A4G-
G5A virus, the delay was 70 h, when compared to WT-VHSV (Fig. 5a).
Table 1
List of terminal RNA sequences of VHSVs and an in silico secondary RNA structure.
RNA sequencea Gene bank
Fil3 (genotype Ia) 30-CAUAGUAUUUUCUA UAAUAAAAGAUAUG_-50 Y18263.1
23–27 (genotype Ia) 30-CAUAGUAUUUUCUA UAAUAAAAGAUAUG_-50 FN665788.1
MI03GL (genotype IVb) 30-CAUAGUAUUUUAUA UAAUAAAAGAUAUGU-50 GQ385941.1
JF00Ehi1 (genotype IVa) 30-CAUAGUAUUUUCUA UAGUAAAAGAUAUG_-50 AB490792.1
KRRV9822 (genotype IVa) 30-CAUAGUAUUUUAUA UAAUAAAAGAUAUG_-50 AB179621.1
JF-09 (genotype IVa) 30-CAUAGUAUUUUCUA UAGUAAAAGAUAUG_-50
Conserved sequence 30-CAUAGUAUUUU_UA UA_UAAAAGAUAUG_-50
Complementary nucleotides G5UA7
30-CAUA4 U8UUU
50-GUAU A AAA
A G
in silico secondary RNA structure (ΔG¼8.43)b
a Different nucleotides among the VHSV RNA sequences are in italics and red color.
b The in silico secondary RNA structure was created by ‘Mfold’ web server.
Table 2
List of primers used for the point mutagenesis and quantitative RT-PCR.
Point mutation at 30-terminal promotera Gene bank
A4G-G5A-Forward gtcagatccgctagcgta CT ataaaagatgatgagttatgttac
A4G-G5A-Reverse gtaacataactcatcatcttttat AG tacgctagcggatctgac
A7C-U8A-Forward gtcagatccgctagcgtatca GT aaagatgatgagttatgttac
A7C-U8A-Reverse gtaacataactcatcatcttt AC tgatacgctagcggatctgac
U8C-Forward gtcagatccgctagcgtatcat G aaagatgatgagttatgttac
U8C-Reverse gtaacataactcatcatcttt C atgatacgctagcggatctgac
30-UTR-Forward cattgacgcaaatgggcggta
30-RACE-Reverse atccacgatcaccttcccatcatctg
Strand-speciﬁc quantitative RT PCR
VHSV-G-Forward ggacacatgatcacagggtg
VHSV-G-Reverse gacagtttcttcgctccccc
Carp-40s-Forward ccgtgggtgacatcgttaca AB012087
Carp-40s-Reverse tcaggacattgaacctcactgtct
Virus replication analysis (in zebraﬁsh)
VHSV-N-Forward cgccatcatgatgagtcggatgctg
VHSV-N-Reverse cttctctgtcaccttgatcccctcc
Zf-β-actin-Forward atggatgaggaaatcgctg AF025305
Zf-β-actin-Reverse atgccaaccatcactccctg
a Target nucleotides are in capital letter and red color.
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Relative rate of virus replication of A4G-G5A virus was drastically lower
(5%), compared to WT-VHSV at 72 h post-infection (Fig. 5b). Signiﬁcant
difference in cytopathic effect (CPE) was detected at 72 h post-infection
between EPC cells infected with A4G-G5A and WT-VHSV (MOI¼1)
(Fig. 6).
All variants (A4G-G5A, A7C-U8A, and U8C) were sequenced by
RACE with a GSP, 30-RACE-Reverse (Table. 2), for the 30-terminal
nucleotides followed by a previously described method (Kim et al.,
2014) with the purpose to ensure that the introduced mutation
was still present following four passages in EPC cells. No mutation
or reversion to wild-type was observed.
Pathogenicity studies in ﬁsh
To study if the observed attenuation would also impact in vivo
virus virulence, we infected zebraﬁsh with these viruses. Since it has
been shown that VHSV is pathogenic to zebraﬁsh after lowering of
the water temperatures, we compared virulence of WT-VHSV and
the A4G-G5A variant. Fish injected i.m. with 4103 TCID50 per ﬁsh
(WT-VHSV) showed close to 90% cumulative percent mortality (CPM)
over a period of 15 days post-challenge in zebraﬁsh (Fig. 7a). When
ﬁsh were injected i.p., the CPM was 83.3%. When the injection dose
was lowered to 4102 TCID50 per ﬁsh (WT-VHSV) by i.m. and i.p.,
both gave 72.2% CPM. Injection of 4103 and 4102 TCID50 per ﬁsh
of A4G-G5A, i.p. resulted in 37.0% and 18.5% CPM, respectively
(Fig. 7a), lowered by more than 50% compared to the WT-VHSV.
There was also a delay in onset of mortality by almost 7 days (Fig. 7a).
When the dose was lowered to 410 TCID50 per ﬁsh for the A4G-
G5A strain, no mortality was seen over a period 15 days post-
challenge. All dead ﬁsh had signs of typical VHSV infection, hemor-
rhagic septicemia, ascites, and exophthalmia. VHSV was detected and
conﬁrmed from randomly sampled dead ﬁsh by cell culture and RT-
PCR. A4G-G5A was detected at early time post-infection by RT-PCR
only in ﬁsh infected with high-doses (Fig. 7b).
Discussion
Here we show that the primary sequence at 30-terminus of VHSV is
important for production of virus progeny in cell culture and patho-
genicity in zebraﬁsh. It has been shown that VSV, a prototype of the
family Rhabdoviridae, has conserved complementary sequence of 30-
and 50-termini which have been studied to understand RNA synthesis
processes (Whelan et al., 2010). A single entry model predicts that a
single polymerase entry site is located at the extreme 30-terminus to
make mRNA or copy viral RNA genome (Emerson, 1982). Later studies
have shown that there are different sites initiating transcription and
replication in the 30-UTR of VSV (Whelan and Wertz, 2002;Chuang and
Perrault, 1997; Qanungo et al., 2004). In NNS RNA viruses, the gene
order is conserved with N, P, and M genes near the 30-terminus and L
gene at the 50-terminus. The 30-terminus promoter sequence seems a
major determinant for control of gene expression in the viral life cycle
(Whelan et al., 2010). The 30- and 50-termini of NNS RNAviruses contain
speciﬁc sequences required for encapsidation of the RNA strand, binding
of the RdRp, leader synthesis, transcription, replication, and assembly/
budding of viral particles (Whelan et al., 2010). For VSV, positions 47–50
of the 30-UTR leader-N gene junction were found essential for tran-
scription and positions 15–50 at the terminus were dispensable for
replication (Whelan and Wertz, 1999). Another study indicated that the
signals for both transcription and replication for VSV were contained
and overlapped within positions 1–24 at the 30-terminus and positions
25–47 were needed for optimal transcription (Li and Pattnaik, 1999).
There are no previous studies addressing the involvement of the
terminal UTRs of novirhabdoviruses. Here we aimed at elucidating the
importance of some positions of the primary sequence of the 30-
terminus of VHSV for virus propogation in vitro and in vivo
pathogenicity using an in silico approach (Table 1). To differentiate
between the positive-strand RNA (mRNA or cRNA) and negative-strand
RNA (vRNA) formation, we used a previously published the ssq RT-PCR
method (Matzinger et al., 2013;Purcell et al., 2006). The A4G-G5A in 30-
terminus had a signiﬁcant negative effect (51% of rWT) on total positive-
strand RNA synthesis (mRNA or cRNA) at 2 days post-transfection
(Fig. 2). However, we cannot clearly differentiate between mRNA
(transcription) and cRNA (replication) synthesis by ssqRT-PCR although
the western blot studies are indicative of lower protein synthesis in the
attenuated variant (A4G-G5A). We would need to follow up using an
RNA assay (like Northern blotting) to differentiate between transcription
and replication. Furthermore, A4G-G5A showed delayed expression of N
and P protein post-infection compared to WT-VHSV (Fig. 3) and it took
5 days for this variant to reach a viral titer (107.55 TCID50/ml) comparable
to WT-VHSV (107.88 TCID50/ml) which plateaued at 4 days post-
infection, likely due to running out of available cells to infect (Fig. 4).
Concurrent with this observation, the A4G-G5A variant also induced full
CPE 70 h later than WT-VHSV (Fig. 5a).
As mentioned earlier, previous studies are indicative of transcrip-
tion and replication being initiated at different sites for VSV, transcrip-
tion initiated at the start of the N-gene (Whelan and Wertz, 2002;
Chuang and Perrault, 1997;Qanungo et al., 2004). Moreover, there is an
alternative possibility that RdRp always enters at the 30-terminus
(scanning) but the transcription is initiated at the start of the N-gene
regardless of the 30-terminus speciﬁc sequence (Whelan et al., 2010).
The template-dependence of NNS RNA viruses for the RNA synthesis
initiation is found to vary. Initiation of VSV is dependent on the ﬁrst
two nucleotides at 30-terminus while for respiratory syncytial virus
(RSV, Paramyxoviridae) initiation is independent of the ﬁrst two
nucleotides on the promoter terminus (Morin et al., 2012;Noton and
Fearns, 2011). The transcription of RSV polymerase could be initiated
at the 3rd nucleotide of the 30-terminal promoter unlike that of VSV
(Tremaglio et al., 2013) and the RSV polymerase–promoter interactions
display sophisticated mechanisms for the viral promoter activity
(Noton et al., 2012;Tremaglio et al., 2013).
Our ﬁndings would be suggestive of the initiation of replication is
affected by the primary sequence near the 30-terminus for VHSV and
positions 4 and 5 play a key role like that of VSV (Whelan and Wertz,
2002;Chuang and Perrault, 1997;Qanungo et al., 2004;Whelan and
Wertz, 2002) and these mutation were found genetically stable.
While it is still not fully understood how the 30-terminal sequences
regulate transcription or/and replication efﬁciency for NNS RNA
viruses in general, we are just beginning to understand how the 30-
terminus regulates these mechanisms for VHSV. This study showed
that the primary sequence is an important promoter but it is not
sufﬁcient to document the importance of any secondary RNA
structure (like double strand RNA promoter). The RNA synthesis
proﬁle should be examined to distinguish between effects of primary
sequence versus secondary structure.
The introduced mutations at the 30-terminus of VHSV affect
formation of virus progeny in vitro and this is also corroborated by
in vivo studies. We used the zebraﬁsh model to study the impact
of mutations on pathogenicity. It has been shown previously that
VHSV is pathogenic to adult zebraﬁsh (Encinas et al., 2010; Novoa
et al., 2006) when the water temperature is lowered to 18 1C and
below. The attenuation for the A4G-G5A strain is consistent over
two virus doses, 4102–4103 TCID50 per ﬁsh, and for the two
doses tested there is a marked drop in end-point mortality
compared to wild type virus (Fig. 7). Injection of 410 TCID50
per ﬁsh of the A4G-G5A variant does not result in mortality
(Fig. 7).
In conclusion this is the ﬁrst study to show the importance of
some positions (A4G5) of the primary sequence at the 30-terminus
as a potential promoter that governs progeny formation in VHSV,
the genus Novirhabdovirus, in vitro. Similarly it is important for
in vivo virulence in zebraﬁsh (Fig. 7).
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Materials and methods
Virus and cells
VHSV (JF-09) was isolated from VHSV-infected olive ﬂounder
(Plathychtis japonicus) (juvenile) in a ﬁsh farm located in South
Korea (June 2009) (Kim et al., 2014). The virus was propagated in
Epithelioma papulosum cyprini (EPC) cells in L15 cell medium
(Invitrogen) containing 10% FBS (Sigma-Aldrich) at 15 1C.
Site-directed mutagenesis
VHSV has conserved complementary RNA sequence in 30-end
(30-CAUAGUAUUUU) and 50-end (UAAAAGAUAUG-50) (Table 1). By
“introducing” a RNA hairpin loop, 30-GGCUUC-50, between con-
served 30- and 50- terminal sequences, it was possible to predict an
in silico secondary RNA structure by ‘Mfold’ web server (Table 1)
(Zuker, 2003;Cheong et al., 1996, 1990;Varaniet al., 1991). Using
the in silico secondary RNA structure as a guide, point-mutations
were introduced mutations in positions A4G5 and A7U8 by site-
directed mutagenesis (GENEARTs, Invitrogen), referred to as A4G-
G5A, A7C-U8A, and U8C. A previously constructed plasmid of
Fig. 1. Viral N protein expression of rescued recombinant VHSVs (1st passage; green ﬂuorescence) in EPC cells (3 parallels) were shown by IFAT at 2 days post-infection. For
the A4G-G5A variant, only a few cells showed positive ﬂuorescence (shown in insert). A non-mutated recombinant VHSV (rWT) was used as a control.
Fig. 2. Relative RNA quantiﬁcation using strand-speciﬁc quantitative RT-PCR.
a) Relative quantiﬁcation of RNA using VHSV-G-Forward/Reverse of different mutants
relative to a non-mutated control plasmid (rWT) at 2 days post-transfection. Negative-
and positive-strand RNA quantiﬁcation of mutated plasmids (A4G-G5A, A7C-U8A, and
U8C). The results are expressed as mean7SEM; n¼3. An asterisk (*) denotes
signiﬁcant reduction (Po0.05) compared to a control reference (rWT). b) Relative
quantiﬁcation of A4G-G5A excluding pL (plasmid encoding the polymerase) showing
background cRNA generation from plasmid (0.8% of pos-strand for A4G-G5A in a).
Fig. 3. Kinetics of viral protein expression of strain A4G-G5A. a) Viral speciﬁc proteins
(Nucleocapsid protein, 42 kDa and Phosphoprotein, 26 kDa) of strain A4G-G5A and
WT-VHSV in cell lysates were detected by western blotting post-infection of EPC cells
(MOI¼1), 48 and 72 h post-infection. b) Expression of VHSV proteins post-transfection
by western blot using polyclonal antibody at 2 and 5 days post-transfection (lane 1:
U8C, lane 2: A4G-G5A, lane 3: A7C-U8A, and lane 4: WT-VHSV).
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complete genome (rJF-09) (Kim et al., 2014) was used for this
purpose. The point-mutated sequences were conﬁrmed by
sequencing (GATC Biotech) with GSPs (30-UTR-Forward, Table 2).
Transfection and characterization of virus infection by IFAT
VHSV plasmids (250 ng), pN (60 ng), pP (50 ng), pL (50 ng), and
pNV (30 ng) were mixed in 25 ml Opti-MEMsmedium (Invitrogen)
and 1.5 ml of FuGENE HD transfection reagent (Roche) was added.
The mixtures were incubated for 10 min at room temperature and
added to sub-conﬂuent layers of EPC cells (1105) in a 24-well
plate. The cells were incubated at 28 1C for 5 h and then trans-
ferred to 15 1C and incubated further for desired time points or till
cytopathic effects (CPE) was evident. The cell culture supernatants
were collected at 4 days post-transfection, clariﬁed by centrifuga-
tion, 10-fold diluted and inoculated onto EPC cells (2105) in a
24-well plate. The cells were incubated at 15 1C for 48 h and ﬁxed
with of 4% paraformaldehyde for 20 min. The rescued viral N
proteins were identiﬁed by using the standard indirect ﬂuorescent
antibody test (IFAT), using MAb IP5B11 as the primary antibody
and Alexa 488 anti-mouse IgG (Molecular Probes, Invitrogen) as
secondary antibody. The stained cells were washed and examined
under an Olympus IX81 ﬂuorescence microscope.
Strand-speciﬁc quantitative RT-PCR
Strand-speciﬁc quantitative RT-PCR (ssqRT-PCR) assay based on
a published method (Matzinger et al., 2013;Troutt et al., 1992;
Purcell et al., 2006) was modiﬁed for our study. VHSV plasmids
(250 ng), pN (60 ng), pP (50 ng), pL (50 ng), and pNV (30 ng) were
mixed in 25 ml Opti-MEMs medium (Invitrogen) and 1.5 ml of
FuGENE HD transfection reagent (Roche) was added. The mixtures
were incubated for 10 min at room temperature and added on sub-
conﬂuent layers of EPC cells (1105) in a 24-well plate. The cells
were incubated at 28 1C for 5 h and shifted to 15 1C. At 2 days post-
transfection, the cells were harvested and total RNA were extracted
from the cells by using a RNeasys Plus Mini kit (Qiagen). To
eliminate background plasmid DNA contamination prior to reverse
transcription, the samples were DNase treated twice (TURBO DNA-
freeTM kit, Ambion). 11 μl of DNase treated total RNA was used as a
template with a single GSP (0.5 μM), VHSV-G-Forward or VHSV-G-
Reverse targeting G protein gene, in a ﬁnal volume of 20 μl to create
strand-speciﬁc cDNA templates (Transcriptor First Strand cDNA
Synthesis kit, Roche). Quantitative RT-PCR was carried out by using
LightCycler 480 SYBR green I master mix and LightCycler 480
Fig. 4. In vitro viral growth pattern following infection of EPC cells (MOI¼0.1). A
non-mutated recombinant VHSV (rWT) and wild-type VHSV (WT) were used as a
control. The titer values are presented as mean7SEM from three parallels.
Fig. 5. Real-time cytopathic effects (CPE) of EPC cells after infection with recombinant VHSV strains (MOI¼0.01). a) CPE was monitored in real-time by use of xCELLigence
(seeMaterial and methods). The results are expressed as mean7SD (n¼3). The ﬁrst time point shown is 72 h post-infection since this was the earliest occurrence of reduced
cell index (CI). b) Viral quantiﬁcation in infected EPC cells (MOI¼0.01) at 72 h post-infection by quantitative RT-PCR. The results are expressed as mean7SEM (n¼3).
Wild-type VHSV (WT) was used as a reference. An asterisk (*) denotes signiﬁcant reduction (Po0.05) compared to WT.
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system (Roche). 2 μl of the strand-speciﬁc cDNA templates were
used with a pair of GSPs (0.5 μM), VHSV-G-Forward and VHSV-G-
Reverse, in a ﬁnal volume of 20 μl. The mixtures were ﬁrst
incubated at 95 1C for 10 min, followed by 40 ampliﬁcation cycles:
10 s at 95 1C, 20 s at 60 1C, and 8 s at 72 1C. Random hexamer
primers (Transcriptor First Strand cDNA Synthesis kit, Roche) were
used for cDNA templates for gene expression of carp 40 s, which is a
reference gene to normalize the data (Joerink et al., 2006). The GSPs
used for strand-speciﬁc quantitative RT-PCR are listed in Table 2. To
compare the impact of pCMV driven cRNA synthesis from the
plasmid relative to viral cRNA (polymerase), the A4G-G5A and
rWT plasmids were transfected into the EPC cells without the pL
helper plasmid followed by ssq RT-PCR.
Western blotting
EPC cells infected by A4G-G5A (2nd passage) and WT-VHSV
(MOI¼1) as described above and cells were lysed by using CelLytic
M reagent (Sigma), at 48 and 72 h post-infection. Proteins were
separated by SDS-PAGE and blotted onto a polyvinylidene diﬂuoride
(PVDF) membrane. The VHSV proteins were detected by western
blotting using polyclonal antibody against VHSV (Ammayappan and
Vakharia, 2011).
Growth kinetics
Growth kinetics was assessed by the TCID50 method and the
VHSV variants (2nd passage, MOI¼0.1) were used to infect EPC
cells (1105) in 24-well plates in three parallels at 15 1C. After
virus infection, the supernatants were collected at designated time
points, clariﬁed by centrifugation and titrated on EPC cells by the
50% tissue culture infective dose (TCID50) method (Kärber, 1931).
For monitoring of cytopathic effects in real-time, VHSV variants
(MOI¼0.01) were used to infect EPC cells (1104) in E-Plates
(xCELLigence, Roche) in three parallels at 15 1C. The xCELLigence
system showed a parameter termed ‘Cell Index’ which is derived
as a relative change in measured electrical impedance and a
correlate of cell status (integrity).
To measure viral replication in the cells by quantitative real-
time RT-PCR, EPC cells (1105) in a 24-well plate were infected by
VHSVs (MOI¼0.01) for the parallel sampling and collection was at
72 h post-infection, a starting point of CPE, at 15 1C. For the viral
replication quantiﬁcation, total RNAs were extracted from infected
cells in a 24-well plate by using a RNeasys Plus Mini kit (Qiagen).
Quantitative real-time RT-PCR was carried out by using Quanti-
Fasts SYBRs Green RT-PCR (Qiagen) and LightCycler 480 system
(Roche). Total RNAs (10 ng) were used as templates with a pair of
GSPs (1 μM), VHSV-G, in a ﬁnal volume of 25 μl. The mixtures
were subject to reverse transcription at 50 1C for 10 min, ﬁrst
incubated at 95 1C for 5 min and followed by 40 ampliﬁcation
cycles: 10 s at 95 1C, 30 s at 60 1C. Carp 40 s, which is a reference
gene, was used to normalize the data (Joerink et al., 2006). The
GSPs used for virus replication are listed in Table 2.
Pathogenicity studies in zebraﬁsh
Wild-type zebraﬁsh (Danio rerio) of 0.5–0.8 g (female:male¼1:1)
were obtained from the zebraﬁsh experimental facility at the Norwe-
gian University of Life Sciences. The ﬁsh were gradually transferred to
lower water temperatures (1 1C per day) and kept to acclimate for
2 days at 16.571 1C before virus infection. The water and feed were
provided from the zebraﬁsh facility. For each experiment, zebraﬁsh
were moved to closed aquaria (6 L) at 16.571 1C and maintained at
these conditions by water exchange (2 L) every day. The water quality
was monitored by daily measurement of ammonia. The ﬁsh were
Fig. 6. a) Cytopathic effects (CPE) in EPC cells 72 h post-infection (MOI¼1). b) The
viral titer 72 h post-infection (mean7SEM; n¼3 parallels). A non-mutated
recombinant VHSV (rWT) and wild-type VHSV (WT) were used as controls.
Fig. 7. a) In vivo viral pathogenicity in zebraﬁsh. Cumulative percentage mortality
(CPM) 15 days post-infection. Zebraﬁsh were infected by intraperitoneal (i.p.)
injection with WT-VHSV (WT), and A4G-G5A at three different doses; 410,
4102 and 4103 TCID50 per ﬁsh. A non-infected control group was injected with
2 ml of L15 medium i.p.. Comparable infection groups are indicated by ‘]’. b) PCR
amplicons (VHSV N gene) in A4G-G5A infected ﬁsh at 1, 3, and 6 days post-
infection. Infection doses (TCID50 per ﬁsh) are shown. Strength of bands is indicated
semi-quantitatively.
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anesthetized with benzocaine and injected intraperitoneally (i.p.) or
intramuscularly (i.m.) at two infection doses for WT-VHSV (4102
TCID50 per ﬁsh or 4103 TCID50 per ﬁsh; 18 ﬁsh per group per dose)
in three parallels using an injection volume of 2 ml and the ﬁsh
injected i.p. at three infection doses for A4G-G5A variant (410
TCID50, 4102 TCID50 or 4103 TCID50; all doses per ﬁsh; 36 ﬁsh per
group per dose) in three parallels using an injection volume of 2 ml.
Control groups were anesthetized and injected with 2 ml of L15
medium. Randomly selected healthy ﬁsh without gross pathology
were decapitated and the whole organs were collected for virus
detection by RT-PCR at early time post-infection. The selected ﬁsh (9
ﬁsh per group) were excluded from estimation of cumulative mor-
tality. The GSPs used for virus replication are listed in Table 2.
Data analysis
The comparative delta delta Ct (2ΔΔCt) method was used to
calculate relative difference of the RNA synthesis in this study
(Livak and Schmittgen, 2001). Speciﬁcity of the PCR products was
ensured by checking the melting temperature and proﬁle of each
melting curve. A t test was used to calculate differences with
P-valueo0.05 considered as signiﬁcantly different.
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